Ja–June Jang

1.4k citations
49 papers · 951 indexed · h-index 17
  • Hepatology top 5%
    • Liver physiology and pathology 5
    • Hepatocellular Carcinoma Treatment and Prognosis 5
    • MicroRNA in disease regulation 3
    • Cancer-related gene regulation 6
    • RNA modifications and cancer 5
    • Epigenetics and DNA Methylation 4
  • Pharmacology top 10%
    • Liver Disease Diagnosis and Treatment 9
    • Cholangiocarcinoma and Gallbladder Cancer Studies 7

Ja–June Jang

49 papers receiving 938 citations

Peers

Ja–June Jang
Comparison fields: 5 of 94
  • Hepatology 186
  • Cancer Research 196
  • Oncology 173
  • Molecular Biology 396
  • Pharmacology 49
Replace Masayoshi Horimoto with:
Masayoshi Horimoto Japan
Gustavo Ferrín Spain
Evelyn Tran United States
Shanzhong Tan China
Sharad Khare United States
Tatsuo Katagishi Japan
Ting‐Fang Lee Taiwan
Alvin Wei Tian Ng Singapore
Laura Conde de la Rosa United States
Fandi Meng China
Ja–June Jang relative to Masayoshi Horimoto Japan Masayoshi Horimoto's profile →
Citations per field
00.5×1.5×2.2×
Masayoshi Horimoto · 1×
Citations per year

Countries citing papers authored by Ja–June Jang

Since Specialization
Citations

This map shows the geographic impact of Ja–June Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ja–June Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ja–June Jang more than expected).

Fields of papers citing papers by Ja–June Jang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ja–June Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ja–June Jang. The network helps show where Ja–June Jang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ja–June Jang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ja–June Jang Line = papers co-authored together Ja–June Jang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201839
2 201810
3 201718
4 20174
5 201639
6 20167
7 201514
8 201520
9 201412
10 201421
11 20136
12 201224
13 201133
14 201137
15 201015
16 200985
17 200816
18 200114
19 19981
20 199828

About Ja–June Jang

Ja–June Jang is a scholar working on Hepatology, Cancer Research and Applied Microbiology and Biotechnology, having authored 49 papers that have together received 951 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer-related gene regulation (6 papers), Liver physiology and pathology (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Hepatology (186 citations), Cancer Research (196 citations) and Oncology (173 citations). Ja–June Jang has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Kyung‐Suk Suh, Kyoung Bun Lee, Gyeong Hoon Kang, Hyo-Suk Lee, Su Jong Yu, Jung‐Hwan Yoon, Yoon Jun Kim, Jeong‐Hoon Lee, Jun-Won Yun and Byeong-Cheol Kang. Their work appears in journals such as Environmental Science & Technology, Scientific Reports and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026